Response to neoadjuvant chemotherapy and effects of tumor regression in gastric cancer

European Journal of Surgical Oncology

Volumn 32, Issue 10, 2006, Pages 1105-1109

  D'Ugo, D ^a   Persiani, R ^b   Rausei, S ^b   Biondi, A ^b   Vigorita, V ^b   Boccia, S ^b   Ricci, R ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Laparoscopic staging; Locally advanced gastric cancer; Neoadjuvant chemotherapy; Pathologic response; Tumor downstaging

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG RESPONSE; FEMALE; FOLLOW UP; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; LAPAROSCOPY; LEUKOPENIA; MALE; NAUSEA; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; STOMACH CARCINOMA; SURVIVAL RATE; THROMBOCYTOPENIA; TUMOR REGRESSION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; EPIRUBICIN; ETOPOSIDE; FEMALE; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 33751167229     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.07.009     Document Type: Article

References (29)

1. Wilke H., Preusser P., Fink U., et al. Preoperative chemotherapy in locally advanced and non-resectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin. J Clin Oncol 7 (1989) 1318-1326
2. Plukker J.T., Mulder N.H., Sleijfer D.T., Grond J., and Verschueren R.C. Chemotherapy and surgery for locally advanced cancer of the cardia and fundus: phase II study with methotrexate and 5-fluorouracil. Br J Surg 78 (1991) 955-958
3. Ajani J.A., Ota D.M., Jessup J.M., et al. Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy. Cancer 68 (1991) 1501-1506
4. Lowy A.M., Mansfield P.F., Leach S.D., Pazdur R., Dumas P., and Ajani J.A. Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer. Ann Surg 229 (1999) 303-308
5. Waters J.S., Norman A., Cunningham D., et al. Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial. Br J Cancer 80 (1999) 269-272
6. Schuhmacher C.P., Fink U., Becker K., et al. Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatinum. Closing results after 5 years of follow-up. Cancer 91 (2001) 918-927
7. Niederhuber J.E. Neoadjuvant therapy. Ann Surg 229 (1999) 309-312
8. Cunningham D., Allum W.H., Stenning S.P., Weeden S., and for the NCRI Upper GI Cancer Clinical Studies Group. Perioperative chemotherapy in operable gastric and lower oesophageal cancer: final results of a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971). J Clin Oncol 23 16S (2005) 4001
9. Siewert J.R., Stein H.J., and von Rahden B.H. Multimodal treatment of gastrointestinal tract tumors: consequences for surgery. World J Surg 29 (2005) 940-948
10. Yonemura Y., Kinoshita K., Fujimura T., et al. Correlation of the histological effects and survival after neoadjuvant chemotherapy on gastric cancer patients. Hepatogastroenterology 43 (1996) 1260-1272
11. Becker K., Mueller J.D., Schuhmacher C., et al. Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer 98 (2003) 1521-1530
12. Picciocchi A., D'Ugo D., Ronconi P., Caracciolo F., Pende V., and Persiani R. The impact of staging laparoscopy on the treatment of locally advanced gastric cancer. J Exp Clin Cancer Res 16 (1997) 84-86
13. Barone C., Cassano A., Pozzo C., et al. Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer. Oncology 67 (2004) 48-53
14. Japanese Research Society for Gastric Cancer. The general rules for gastric cancer study in surgery and pathology: part I. Jpn J Surg 11 (1981) 127-139
15. Park J.O., Lee S.I., Song S.Y., et al. Measuring response in solid tumors: comparison of RECIST and WHO response criteria. Jpn J Clin Oncol 33 (2003) 533-537
16. Becker K., Fumagalli U., Mueller J.D., Fink U., Siewert J.R., and Hofler H. Neoadjuvant chemotherapy for patients with locally advanced gastric carcinoma: effect on tumor cell microinvolvement of regional lymph nodes. Cancer 85 (1999) 1484-1489
17. Kaplan E.L., and Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
18. Cox D.R., and Oakes D. Analysis of survival data. Monographs on statistics and applied probability (1984), Chapman and Hall, London
19. Miller A.B., Hoogstraten B., Staquet M., and Winkler A. Reporting results of cancer treatment. Cancer 47 (1981) 207-214
20. Sobin L.H., and Wittenkind C. TNM classification of malignant tumors. 6th edition (2002), John Wiley & Sons, Inc., New York
21. Shimada K., and Ajani J.A. Adjuvant therapy for gastric carcinoma patients in the past 15 years: a review of western and oriental trials. Cancer 86 (1999) 1657-1668
22. Lim L., Michael M., Mann G.B., and Leong T. Adjuvant therapy in gastric cancer. J Clin Oncol 23 (2005) 6220-6232
23. Persiani R., D'Ugo D., Rausei S., et al. Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy. J Surg Oncol 89 (2005) 227-236
24. Böttcher K., Stein H.J., and Becker K. Stomach carcinoma. In: Roder J.D., Stein H.J., and Fink F. (Eds). Therapy of gastro-intestinal tumors (2000), Springer, Berlin 217-241
25. Kim J.P., Lee J.H., Kim S.J., Yu H.J., and Yang H.K. Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer. Gastric Cancer 1 (1998) 125-133
26. Kiyabu M., Leichman L., and Chandrasoma P. Effects of preoperative chemotherapy on gastric adenocarcinomas. A morphologic study of 25 cases. Cancer 70 (1992) 2239-2245
27. Kumagai K., Ishibashi Y., and Yasui A. Effects of preoperative chemotherapy on gastric carcinoma: the relationship between histopathologic response and prognosis. Clin Ther 17 (1995) 936-945
28. Hohenberger P., and Gretschel S. Gastric cancer. Lancet 362 (2003) 305-315
29. D'Ugo D.M., Persiani R., Caracciolo F., Ronconi P., Coco C., and Picciocchi A. Selection of locally advanced gastric carcinoma by preoperative staging laparoscopy. Surg Endosc 11 (1997) 1159-1162